Going into Rx - Must I go to business school eventually?

So I am gonna be joining a top rx shop post grad (think PJT, HL, EVR, LAZ) and I am probably looking to continue a career in distressed investing (PE or HF) as it seems really interesting and exciting while providing a much more complex skillset that would allow me to transition back into traditional HF/PE work if I really wanted to leave that world. I kinda want to avoid business school if possible because it just seems like a really expensive 2 year vacation (just my opinion, wtf do i know) plus I have taken a couple of MBA classes as an undergrad. I really would just like to continue working.

The real question is if I will be pushed to go get an MBA by the firm I work at. I'm sure that at larger 'megafund' types that do distressed (Blackstone, Apollo and the like) most of the associates are definitely incentivized to go get an MBA but what about at some of the firms in the space that are less visible in the public eye (GoldenTree, Canyon, Crescent, Silver Point etc)? A quick LinkedIn search tells me a good portion of the individuals working at these firms do eventually go off to get MBAs, but are they likely to loosen their stance on MBAs in the future? I just don't really see why after a few years of picking up such a niche and detailed skill-set why business school would provide any value-add apart from appeasing LPs lol.

4 Comments
 

Understood, but in addition to not knowing where you'll be in 3 years, you can't really predict how you're going to feel about your career and an MBA. After 5-6 years in finance, you may just decide that you want to reset and start your own business or work in a sector that you enjoyed covering. You may decide you want a two year break before you go back to PE or whatever. For now at least, you don't want to get an MBA, thats fine. Nobody's going to force you to get one, and you can cross that bridge in another 3 years when you're deciding on what you want to do.

 
Most Helpful

Officiis quia ea minus ut aut alias sequi. Et esse dolor corporis sit. Voluptatem distinctio a facere. Totam aut beatae eaque incidunt quia sit qui.

Et eligendi ratione velit praesentium debitis. Necessitatibus eaque incidunt voluptates quis harum. Enim et neque recusandae consequatur repellendus aut.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
GameTheory's picture
GameTheory
98.9
6
DrApeman's picture
DrApeman
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”